[ORGANIZATION]
Central Drugs Standard Control Organisation
Featured in 16 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
330 clusters · 1193 sources · last updated
Latest: GLP-1 weight-loss drugs linked to lower diabetes and mortality risks
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. A large observational study
Also covered in
-
Delhi Court discharges former CDSCO official in CBI bribery case
[CRIME] · 2 sources ·
-
CDSCO cancels FatX registration over misleading product claims
[BUSINESS] · 4 sources ·
-
Dr. Reddy’s receives DCGI approval for Zytorvi to treat esophageal cancer
[HEALTH] · 2 sources ·
-
India launches pilot dengue vaccination drive in Tamil Nadu
[HEALTH] · 2 sources ·
-
India regulates wearables based on intended use
[TECHNOLOGY] · 2 sources ·
-
India commits to eliminating Hepatitis B and C by 2030
[HEALTH] · 4 sources ·
-
CDSCO warns of kidney disease risks from painkiller and antibiotic misuse
[HEALTH] · 8 sources ·
-
India issues health alert over Pakistan-made whitening creams
[HEALTH] · 4 sources ·
-
Abhayrab rabies vaccine batch flagged as substandard in Delhi
[HEALTH] · 5 sources ·
-
Lupin Limited receives U.S. FDA approval and updates insulin trials
[BUSINESS] · 2 sources ·